Compound ID | 171
Class: Antivirulence agent (T3SS inhibitor)
Spectrum of activity: | Gram-negative |
Details of activity: | Phenoxyacetamide inhibitor of Pseudomonas aeruginosa type III secretion system |
Institute where first reported: | Microbiotix Inc, USA |
Year first mentioned: | 2014 |
Highest developmental phase: | Preclinical |
Development status: | Active |
Chemical structure(s): | |||||||||||
|
|